The most recent Success stories from EU Research. Select a theme or country from the menus on the left to see more articles
Tick (check) box to add article to PDF "basket"
Published: 6 January 2017
EU citizens will be able to compare cancer incidence and survival rates across Member States once a continent-wide cancer information system is operational next year, according to Professor Alexander Katalinic, from the University of Lubeck in Germany, Chairman of the European Network of Cancer Registries (ENCR).
Published: 25 November 2016
An ERC-funded project has significantly increased understanding of the crucial role that microorganisms in the gut play in maintaining health. The findings have since led to a patent, as well as a follow-on project that could one day steer the way to new targeted treatments for diseases, including cancer.
Published: 18 November 2016
Pioneering new microscopic techniques capable of achieving accurate 3D protein models could one day lead to new cancer therapies and treatments for diseases such as Alzheimer's. Developed by EU-funded researchers, the techniques have also been used to study how to improve antimalarial drugs.
Published: 22 September 2016
EU-funded project ULTRAPLACAD is developing a low-cost device that can detect the early signs of cancer by analysing blood. The device would allow doctors to screen more patients and provide treatment at an earlier stage of the disease - helping to save lives.
Published: 16 September 2016
Dendritic cells are a type of white blood cell. By studying them, an EU-funded project aims to provide wider insights into the role of the immune system in the development of cancer. The insights provided by the project could eventually help researchers develop new ways to fight a range of cancers - helping to save lives.
Published: 16 September 2016
A robot named 'Little Casper' has been designed to help children in hospital suffering from cancer. It is currently being tested at this hospital in Lisbon. Little Casper is just not an ordinary robot. He was built to perceive the environment and to interact with it.
Published: 2 August 2016
Haematopoietic Stem Cells (HSCs) are blood cells located in the bone marrow. These cells are extensively used in research to develop treatments for many severe diseases, including HIV and multiple sclerosis, and their transplant is a key therapy for certain types of cancer like leukemia and multiple myeloma. However, the use of HSCs is seriously constrained by their limited availability since growing them in the lab does not produce very large quantities. There is therefore an urgent need for methods allowing scientists to multiply HSCs, without losing any of their properties.
Published: 20 July 2016
Developing new anti-cancer treatments is expensive, and national, public funding organisations across Europe dedicate substantial resources to this task. Linking their research programmes helps to ensure these funds are used to best effect. The ERA-Net Transcan is now continuing as the ERA-Net Cofund Transcan-2 network, fostering long-term transnational research synergy.
Published: 8 June 2016
EU-funded project PRISAR is developing a hybrid probe that doctors can use to more precisely target cancerous tumours in image-guided surgery and during post-operative radiotherapy treatment. The project aims to improve treatments for cancer patients and save more lives.
Published: 11 May 2016